Human CX3CL1/Fractalkine protein (Recombinant) (C-6His) (STJP001892)

SPECIFICATIONS
HostPichia
ConjugationUnconjugated
ImmunogenRecombinant Human CX3CL1/Fractalkine Protein is produced by Pichia expression system. The target protein is expressed with sequence (Gln25-Gly100) of human CX3CL1/Fractalkine (Accession #NP_002987.1) fused with and a 6×His tag at the C-terminus.
STJP001892
🚚 Free UK Delivery on orders over £150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionRecombinant-Human CX3CL1/Fractalkine-C-6His protein was developed in pichia using the region Gln25-Gly100. For use in research applications.
HostPichia
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ConjugationUnconjugated
FormulationLyophilised from a 0.22 Mu m filtered solution of PBS, pH 7.4.
Storage InstructionStore at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Determination Method<0.1 EU/Mu g

Target Information

Gene SymbolCX3CL1
Gene ID6376
Uniprot IDX3CL1_HUMAN
ImmunogenRecombinant Human CX3CL1/Fractalkine Protein is produced by Pichia expression system. The target protein is expressed with sequence (Gln25-Gly100) of human CX3CL1/Fractalkine (Accession #NP_002987.1) fused with and a 6×His tag at the C-terminus.
Immunogen RegionGln25-Gly100
Immunogen SequenceQHHGVTKCNITCSKMTSKIP VALLIHYQQNQASCGKRAII LETRQHRLFCADPKEQWVKD AMQHLDRQAAALTRNG

Additional Info

Post Translational Modifications A soluble short 95 kDa form may be released by proteolytic cleavage from the long membrane-anchored form. O-glycosylated with core 1 or possibly core 8 glycans.
Function Chemokine that acts as a ligand for both CX3CR1 and integrins ITGAV:ITGB3 and ITGA4:ITGB1. The CX3CR1-CX3CL1 signaling exerts distinct functions in different tissue compartments, such as immune response, inflammation, cell adhesion and chemotaxis. Regulates leukocyte adhesion and migration processes at the endothelium. Can activate integrins in both a CX3CR1-dependent and CX3CR1-independent manner. In the presence of CX3CR1, activates integrins by binding to the classical ligand-binding site (site 1) in integrins. In the absence of CX3CR1, binds to a second site (site 2) in integrins which is distinct from site 1 and enhances the binding of other integrin ligands to site 1. Processed fractalkine: The soluble form is chemotactic for T-cells and monocytes, but not for neutrophils. Fractalkine: The membrane-bound form promotes adhesion of those leukocytes to endothelial cells. (Microbial infection) Mediates the cytoadherence of erythrocytes infected with parasite P.falciparum (strain 3D7) with endothelial cells by interacting with P.falciparum CBP1 and CBP2 expressed at the surface of erythrocytes. The adhesion prevents the elimination of infected erythrocytes by the spleen (Probable).
Protein Name Fractalkine
C-X3-C Motif Chemokine 1
Cx3c Membrane-Anchored Chemokine
Neurotactin
Small-Inducible Cytokine D1 Cleaved Into - Processed Fractalkine
Database Links Reactome: R-HSA-380108
Reactome: R-HSA-418594
Cellular Localisation Cell Membrane
Single-Pass Type I Membrane Protein
Processed Fractalkine: Secreted
Alternative Protein Names Fractalkine protein
C-X3-C Motif Chemokine 1 protein
Cx3c Membrane-Anchored Chemokine protein
Neurotactin protein
Small-Inducible Cytokine D1 Cleaved Into - Processed Fractalkine protein
CX3CL1 protein
FKN protein
NTT protein
SCYD1 protein
A-152E5.2 protein

Information sourced from Uniprot.org

Citations

Product Review

Well-cited Academic Publications
KO-Validated 700+ Lines
Technical Support Expert Scientific Team
1-Year Guarantee Antibodies & Proteins